But will there be any side effects from this approach? How will it affect the treatment or the body? Patients are more concerned about these kinds of problems. At the root of this, why does chemotherapy cause a decline in white blood cells? How to deal with this problem?

　　First, let's take a look at what causes the decline in white blood cells. There is a concept to mention here called myelosuppression. The bone marrow is responsible for hematopoiesis, such as white blood cells, red blood cells and platelets. These cells play important roles, including blood clotting and immunity, and play a very important role in the stable functioning of the body's systems. The stem cells in the bone marrow divide and differentiate in this process to replace the red blood cells that are quickly inactive and the white blood cells that have died due to immune function. Myelosuppression, as the name suggests, is when the action of the bone marrow is suppressed. The reason for the inhibition lies in the drugs used in chemotherapy.

　  Cancer cells are essentially an out-of-control, rapidly and continuously dividing group of cells. Doesn't it sound familiar? Yes, cancer cells are similar to stem cells in some ways, so when drugs inhibit cancer cells, they often affect normal stem cells, resulting in bone marrow suppression, which in turn causes a series of physiological problems. When myelosuppression occurs, the number of white blood cells decreases first, followed by platelets and red blood cells.

　　Clinically, the number of white blood cells and platelets is often measured to understand the degree of bone marrow suppression and determine the next treatment policy. Note: Because myelosuppression is delayed and does not appear until about the third day after chemotherapy, testing is required at that time. The results of the just-concluded examination are not based and cannot be used as a criterion for judgment.

　　The decline in white blood cells will inevitably affect the patient's physical condition, because the white blood cells are responsible for immunity, at this time the immunity will be greatly reduced, it is easy to get infected, and it is easy to be attacked by other diseases, even the common cold will have a great impact on the patient. And when the white blood cells drop to a certain level, the patient will not be able to withstand the next course of chemotherapy, and the common method is to take medicine or injections. However, this is only a temporary method, not to restore the function of the bone marrow, but only to solve the problem superficially, although the white blood cells are temporarily raised, but soon they will fall again.

    Shengbai oral liquid (mixture) has an anti-apoptotic effect on bone marrow cells, fundamentally protects the bone marrow, and prevents and treats bone marrow suppression caused by chemotherapy. Simultaneous administration of raw white oral solution (mixture) before and during chemotherapy can protect the bone marrow, promote the proliferation of hematopoietic stem cells, increase the number of white blood cells, and prevent and treat bone marrow suppression during chemotherapy. Taking Shengbai oral liquid (mixture) after chemotherapy can restore bone marrow function, prevent rebound, and consolidate the efficacy of chemotherapy. In addition, Shengbai Oral Liquid (Mixture) has the effect of promoting secretion and sensitizing of endogenous G-CSF, which can effectively reduce the incidence of leukocytopenia, reduce the degree of leukocytopenia, improve the level of leukocytes in patients, and truly escort the chemotherapy of patients.